The rising prevalence of brain diseases has a significant impact on the market. As the prevalence of brain diseases such as Alzheimer's disease, Parkinson's disease, and other forms of dementia continues to rise globally, there is a corresponding increase in public awareness about the importance of brain health. This heightened awareness leads to greater demand for brain health supplements among individuals.
Moreover, supplements for enhancing cognitive function have mostly focused on aging baby boomers to help slow down or prevent cognitive disorders. With the development and awareness about these products, they are now more closely targeted at millennials, as this demographic is under constant pressure to increase its productivity.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Brain health supplements industry size was valued at USD 9.2 billion in 2023 and is expected to reach USD 19.3 billion by 2032, driven by growing awareness regarding mental health, particularly targeting lack of focus and attention, anxiety, declining memory, and depression.
The herbal extract type segment reached a revenue of USD 4 billion in 2023 and is set to gain traction by 2032, driven by the growing inclination towards herbal nutraceutical products in developing countries, such as China and India.
North America brain health supplements industry held a significant share in 2023 and is expected to dominate throughout 2032, driven by the increasing prevalence of brain disorders, growing emphasis on mental wellness, increasing stress levels, and product launches.
Accelerated Intelligence Inc., Alternascript, HVMN Inc., Intelligent Labs, Natural Factors USA, NOW Foods, Onnit Labs, Inc., Purelife Bioscience Co., Ltd, Quincy Bioscience, Reckitt Benckiser Group PLC are some of the major industry contenders.